To compare the efficacy of [ Forty-nine patients (median age, 57 years; IQR, 51-66 years) with histologically proven primary or relapsed EOC were enrolled. Participants underwent [ Among the 49 patients, 28 had primary EOC; 21 had relapsed EOC. [ [ NCT05034146. Registered February 23, 2021.